NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Cycle-Powered Short Radius (1.9 m) Centrifuge: Effect of Exercise Versus Passive Acceleration on Heart Rate in HumansIn addition to extensive use of lower extremity physical exercise training as a countermeasure for the work capacity component of spaceflight deconditioning, some form of additional head-to-foot (+Gz) gravitational (orthostatic) stress may be required to further attenuate or prevent the signs and symptoms (nausea, vertigo, instability, fatigue) of the general reentry syndrome (GRS) that can reduce astronaut performance during landing. Orthostatic (head-to-foot) stress can be induced by standing, by lower body negative pressure, and by +Gz acceleration. One important question is whether acceleration training alone or with concurrent leg exercise would provide sufficient additive stimulation to attenuate the GRS. Use of a new human-powered centrifuge may be the answer. Thus, the purpose for this study was to compare heart rate (HR), i.e., a stress response during human-powered acceleration, in four men (35-62 yr) and two women (30-31 yr) during exercise acceleration versus passive acceleration (by an off-board operator) at 100% (maximal acceleration = A(max)), and at 25%, 50%, and 75% of A(max). Mean (+/-SE) A(max) was 43.7 +/- 1.3 rpm (+3.9 +/- 0.2Gz). Mean HR at exercise A(max) was 189 +/- 13 b/min (50-70 sec run time), and 142 +/- 22 b/min at passive A(max) (40-70 sec run time). Regression of mean HR on the various +Gz levels indicated explained variance (correlations squared) of r(exp 2) = 0.88 (exercise) and r(exp 2) = 0.96 (passive): exercise HR of 107 +/- 4 (25%) to 189 +/- 13 (100%) b/min were 43-50 b/min higher (p less than 0.05) than comparable passive HR of 64 +/- 2 to 142 +/- 22 b/min. Thus, exercise adds significant physiological stress during +Gz acceleration. Inflight use of this combined exercise and acceleration countermeasure may maintain work capacity as well as normalize acceleration and orthostatic tolerances which could attenuate or perhaps eliminate the GRS.
Document ID
19970011171
Acquisition Source
Ames Research Center
Document Type
Technical Memorandum (TM)
Authors
Greenleaf, J. E.
(NASA Ames Research Center Moffett Field, CA United States)
Gundo, D. P.
(NASA Ames Research Center Moffett Field, CA United States)
Watenpaugh, D. E.
(NASA Ames Research Center Moffett Field, CA United States)
Mulenburg, G. M.
(NASA Ames Research Center Moffett Field, CA United States)
Mckenzie, M. A.
(NASA Ames Research Center Moffett Field, CA United States)
Looft-Wilson, R.
(NASA Ames Research Center Moffett Field, CA United States)
Hargens, A. R.
(NASA Ames Research Center Moffett Field, CA United States)
Date Acquired
September 6, 2013
Publication Date
February 1, 1997
Subject Category
Life Sciences (General)
Report/Patent Number
NAS 1.15:110433
NASA-TM-110433
A-975618
Accession Number
97N16183
Funding Number(s)
PROJECT: RTOP 199-21-12-07
Distribution Limits
Public
Copyright
Work of the US Gov. Public Use Permitted.
No Preview Available